Early-life risk factors for non-Hodgkin lymphoma

May 22, 2012

Factors influencing early life non-Hodgkin lymphoma (NHL) incidence include family characteristics, high fetal growth, older maternal age, low birth order, and male gender, according to a study published May 22 in the Journal of the National Cancer Institute.

Over the last 50 years, NHL incidence increased substantially, although the overall incidence started to stabilize in the 1990s, at least among adults. But incidence has continued to climb in children, adolescents, and young adults. Perinatal factors have been thought to increase NHL risk, but previous studies of those factors were limited due to small sample sizes, wide variability in adjustment for confounding, and possible selection bias such as socioeconomic circumstances.

In order to determine the cause of NHL incidence in children, adolescents, and young adults, Casey Crump, M.D., Ph.D., of the Department of Medicine at Stanford University and colleagues, conducted a national of more than 3.5 million people born in Sweden between 1973-2008 who were followed for NHL incidence through 2009. Information on perinatal and family characteristics and NHL diagnoses were attained through linkage of national birth and cancer registries, and Cox proportional hazard models were used to assess association of those characteristics with the risk of NHL.

The researchers found that genetics and in utero conditions contributed to the incidence of NHL in adolescents. The strongest link was a family history of NHL in either a sibling or parent. A high fetal growth rate, older maternal age, and low birth order also played a key role in . Male gender was linked with NHL incidence in children younger than age 15, but not with later onset of NHL. "These findings suggest several heterogeneous mechanisms including possible growth factor pathways in utero, immunologic effects of delayed infectious exposures, as well as other unmeasured environmental and ," the authors write. "Further elucidation of these risk factors may facilitate the identification of high-risk individuals at young ages and potentially enable earlier detection and treatment."

In an accompanying editorial, William F. Anderson, M.D., M.P.H., and Benjamin Emmanuel, MPH, of the at the Division of Cancer Epidemiology and Genetics, write that this is a "well-performed national cohort study," but point out certain limitations, including: the unavailability of host and environmental risk factors such as radiation and environmental contaminants. They also point out the small number of case patients. However, they conclude that the study's, "large-scale and population-based design minimized selection bias and maximized generalizable conclusions for associations between NHL in early life and family history, high weight, older , low birth order, and male sex."

Explore further: Body weight, diet may be risk factors for non-Hodgkin lymphoma

Related Stories

Body weight, diet may be risk factors for non-Hodgkin lymphoma

October 24, 2011
Body weight in young adulthood and diet appeared to be associated with the risk for non-Hodgkin lymphoma, according to results presented at the 10th AACR International Conference on Frontiers in Cancer Prevention Research, ...

Wilmot scientists describe current, future challenges in lymphoma

April 14, 2011
(PhysOrg.com) -- A special edition of the highly regarded Journal of Clinical Oncology, placed online this week, spotlights James P. Wilmot Cancer Center physicians who write about progress and opportunities in caring for ...

Recommended for you

Study prompts new ideas on cancers' origins

December 16, 2017
Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the ...

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.